Ovid Application Error
Etidronate therapy for hypercalcemia in subcutaneous fat necrosis of the newborn. Rice, Alan M. MD; Rivkees, Scott A. MD [Article] Journal of Pediatrics. 134(3):349-351, March 1999.
(Format: HTML)
Subcutaneous fat necrosis of the newborn (SCFN) is characterized by indurated violet skin nodules and, occasionally, life-threatening hypercalcemia. Current treatments of patients with SCFN-related hypercalcemia are often only partially successful and may be associated with prolonged hypercalcemia. We now report the use of etidronate, a bisphosphanate, to control hypercalcemia in an infant with SCFN. (J Pediatr 1999;134:349-51)
(C) Mosby-Year Book Inc. 1999. All Rights Reserved.